Authors: YANG B RICE TW ADELSTEIN D RYBICKI L GOLDBLUM JR

Citation: B. Yang et al., OVEREXPRESSION OF P53 PROTEIN AS A PREDICTOR OF RESPONSE TO INDUCTIONCHEMORADIOTHERAPY FOR ESOPHAGEAL-CARCINOMA, Modern pathology, 11(1), 1998, pp. 73-73

Authors: HANNA E WANAMAKER J ADELSTEIN D TUBBS R LAVERTU P

Citation: E. Hanna et al., EXTRANODAL LYMPHOMAS OF THE HEAD AND NECK - A 20-YEAR EXPERIENCE, Archives of otolaryngology, head & neck surgery, 123(12), 1997, pp. 1318-1323

Authors: CHIDEL M RICE TW KUPELIAN PA ADELSTEIN D BECKER M

Citation: M. Chidel et al., THE USE OF NEOADJUVANT CHEMORADIOTHERAPY FOR RESECTABLE ESOPHAGEAL CANCER, Radiology, 205, 1997, pp. 1082-1082

Authors: GOLDBLUM JR RICE TW MEDENDORP S ADELSTEIN D

Citation: Jr. Goldblum et al., PREDICTION OF RESPONSE TO INDUCTION CHEMORADIOTHERAPY FOR ESOPHAGEAL-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY OF 57 PATIENTS, Laboratory investigation, 76(1), 1997, pp. 313-313

Authors: BUDD GT LORENZI V GANAPATHI R ADELSTEIN D PELLEY R OLENCKI T MCLAIN D BUKOWSKI RM

Citation: Gt. Budd et al., AMIFOSTINE - POTENTIAL FOR CLINICALLY USEFUL CYTOPROTECTION, Supportive care in cancer, 2(6), 1994, pp. 380-384

Authors: BUDD GT GANAPATHI R BAUER L MURTHY S ADELSTEIN D WEICK J GIBSON V MCLAIN D SERGI J BUKOWSKI RM

Citation: Gt. Budd et al., PHASE-I STUDY OF WR-2721 AND CARBOPLATIN, European journal of cancer, 29A(8), 1993, pp. 1122-1127